These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 12372643

  • 21. A model of cochlear function assessment during reversible ischemia in the Mongolian gerbil.
    Mom T, Avan P, Bonfils P, Gilain L.
    Brain Res Brain Res Protoc; 1999 Dec; 4(3):249-57. PubMed ID: 10592332
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Ischemia-reperfusion injury of the cochlea: effects of an iron chelator and nitric oxide synthase inhibitors.
    Tabuchi K, Tsuji S, Asaka Y, Hara A, Kusakari J.
    Hear Res; 2001 Oct; 160(1-2):31-6. PubMed ID: 11591488
    [Abstract] [Full Text] [Related]

  • 26. Protection of outer hair cells from reperfusion injury by an iron chelator and a nitric oxide synthase inhibitor in the guinea pig cochlea.
    Tabuchi K, Okubo H, Fujihira K, Tsuji S, Hara A, Kusakari J.
    Neurosci Lett; 2001 Jul 06; 307(1):29-32. PubMed ID: 11516567
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Nitrosoglutathione suppresses cochlear potentials and DPOAEs but not outer hair cell currents or voltage-dependent capacitance.
    Nenov AP, Skellett RA, Fallon M, Bobbin RP.
    Hear Res; 1997 Aug 06; 110(1-2):77-86. PubMed ID: 9282890
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose-dependency of electrophysiological and morphological effects.
    O'Leary SJ, Klis SF, de Groot JC, Hamers FP, Smoorenburg GF.
    Hear Res; 2001 Apr 06; 154(1-2):135-45. PubMed ID: 11423224
    [Abstract] [Full Text] [Related]

  • 36. Effects of a dopaminergic agonist in the guinea pig cochlea.
    d'Aldin C, Puel JL, Leducq R, Crambes O, Eybalin M, Pujol R.
    Hear Res; 1995 Oct 06; 90(1-2):202-11. PubMed ID: 8974998
    [Abstract] [Full Text] [Related]

  • 37. Specialized features of the outer hair cell shapes in the cochlear fovea of bats.
    Zhang SQ, Li SL, Zhu HL, Yan LY.
    Genet Mol Res; 2015 Aug 14; 14(3):9530-42. PubMed ID: 26345886
    [Abstract] [Full Text] [Related]

  • 38. Ethacrynic acid rapidly and selectively abolishes blood flow in vessels supplying the lateral wall of the cochlea.
    Ding D, McFadden SL, Woo JM, Salvi RJ.
    Hear Res; 2002 Nov 14; 173(1-2):1-9. PubMed ID: 12372630
    [Abstract] [Full Text] [Related]

  • 39. Cochlear protection from carbon monoxide exposure by free radical blockers in the guinea pig.
    Fechter LD, Liu Y, Pearce TA.
    Toxicol Appl Pharmacol; 1997 Jan 14; 142(1):47-55. PubMed ID: 9007033
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.